Skip to main content
×
×
Home

Combining depot antipsychotic medications with novel antipsychotics in forensic patients: a practice in search of a principle

  • Jatinder J. S. Bains (a1) and Olav B. Nielssen (a2)
Abstract
OBJECTIVE

We observed a pattern of combining depot antipsychotic medication with the newer ‘atypical’ antipsychotics in forensic patients. We aimed to determine the prevalence and rationale for such ‘combination therapy’.

METHOD

The medical records of forensic patients in 3 forensic hospitals in New South Wales, Australia, were reviewed and the responsible psychiatrists asked to explain the rationale for treatment of those patients on combination therapy.

Results

Twenty-two per cent of the forensic patient population were receiving combination therapy. The reasons given for combination therapy were the presence of treatment-resistant illness, to ensure adherence to at least part of the treatment and to assist transfer to lower security units.

CONCLUSIONS

Such a high prevalence of a practice that is discouraged and without theoretical justification is a cause for concern. It appeared to reflect the practical difficulties of managing forensic patients.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Combining depot antipsychotic medications with novel antipsychotics in forensic patients: a practice in search of a principle
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Combining depot antipsychotic medications with novel antipsychotics in forensic patients: a practice in search of a principle
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Combining depot antipsychotic medications with novel antipsychotics in forensic patients: a practice in search of a principle
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
American Psychiatric Association (1997) Practice guidelines for the treatment of patients with schizophrenia. American Journal of Psychiatry, 154, April Suppl., 163.
Beck, N. C., Greenfield, S. R., Gotham, H., et al (1997) Risperidone in the management of violent, treatment-resistant schizophrenics hospitalized in a maximum security forensic facility. Journal of the American Academy of Psychiatry and Law, 25, 461468.
Brecher, M. (1996) Long termsafety of risperidone (abstract P-15-1). European Neuropsychopharmacology, 6, suppl. 3, 170.
British Medical Association & Royal Pharmaceutical Society of Great Britain (2001) British National Formulary (March issue). London & Wallingford: BMJ Books & Pharmaceutical Press.
Daniel, D. G. & Whitcomb, S. R. (1998) Treatment of the refractory schizophrenic patient. Journal of Clinical Psychiatry, 59, suppl. 1, 1319, discussion 20–1.
Duncan, J. C. & Rogers, R. (1998) Medication compliance in patients with chronic schizophrenia; implications for the community management of mentally disordered offenders. Journal of Forensic Psychiatry, 43, 11331137.
Frankenburg, F. R. (1999) Choices in antipsychotic therapy in schizophrenia. Harvard Research Review, 6, 241249.
Lambert, T. & Singh, B. (2000) Psychotropic prescribing in community mental health clinics. International Journal of Neuropsychopharmacology, 3 (suppl.1), S123.
Norrie, P. D. & Hustig, H. H. (1998) A relevant indication for polypharmacy? The use of Zuclopenthixol with Risperidone or Olanzapine inpatients with treatment resistant schizophrenia. Poster 21st CINP, Glasgow, July 12–16.
Pantelis, C. & Barnes, T. R. (1996) Drug strategies and treatment-resistant schizophrenia. Australian and New Zealand Journal of Psychiatry, 30, 2037.
Swartz, M. S., Swanson, J.W., Hiday, V. A., et al (1998) Taking the wrong drugs: the role of substance abuse and medication noncompliance in violence among severely mentally ill individuals. Social Psychiatry and Psychiatric Epidemiology, 33, suppl.1, S7580.
Thompson, C. (1994) The use of high dose antipsychotic medication. British Journal of Psychiatry, 164, 448458.
Umbricht, D. & Kane, J. M. (1996) Understanding the relationship between extrapyrimidal side effects and tardive dyskinesia. In Serotonergic Mechanisms in Antipsychotic Treatment (eds. Kane, J. M., Moller, H. J. & Awouters, E.), pp. 221251. NewYork: Marcel Dekker.
Weiden, P. J., Aquila, R., Emanuel, M., et al (1998) Long term considerations after switching antipsychotics. Journal of Clinical Psychiatry, 159, suppl. 19, 3649.
Young, J. L., Zonana, H.V. & Shepler, L. (1986) Medication noncompliance in schizophrenia: codification and update. Bulletin of the American Academy of Psychiatry and Law, 14, 105122.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 7 *
Loading metrics...

Abstract views

Total abstract views: 28 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 23rd June 2018. This data will be updated every 24 hours.

Combining depot antipsychotic medications with novel antipsychotics in forensic patients: a practice in search of a principle

  • Jatinder J. S. Bains (a1) and Olav B. Nielssen (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *